Ignite Creation Date:
2024-05-05 @ 5:32 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00479778
Status:
COMPLETED
Last Update Posted:
2007-12-28
First Post:
2007-05-25
Brief Title:
Study Of Pharmacokinetic PK Profile of Bazedoxifene BZA in 2 BZAConjugated Estrogen Forms
Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Organization:
Wyeth is now a wholly owned subsidiary of Pfizer
Study Overview
Official Title:
An Open Label Randomized Multicenter Study To Compare Bazedoxifene Steady-State Exposures Obtained With 2 Bazedoxifene AcetateConjugated Estrogen Formulations In Postmenopausal Women
Status:
COMPLETED
Status Verified Date:
2007-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the study is to understand how bazedoxifene is absorbed in the body when it is given in combination with 2 different formulations of conjugated estrogens It is an open label study with no placebo control or comparator drugs Subjects will take one dose of the investigation formulation daily for 14 days
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None